Japan Medical (Germany) Performance
JMD Stock | EUR 3.70 0.08 2.21% |
The company retains a Market Volatility (i.e., Beta) of 0.23, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Japan Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Japan Medical is expected to be smaller as well. At this point, Japan Medical Dynamic has a negative expected return of -0.39%. Please make sure to check out Japan Medical's total risk alpha, maximum drawdown, skewness, as well as the relationship between the treynor ratio and potential upside , to decide if Japan Medical Dynamic performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Japan Medical Dynamic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Begin Period Cash Flow | 2.5 B |
Japan |
Japan Medical Relative Risk vs. Return Landscape
If you would invest 470.00 in Japan Medical Dynamic on August 25, 2024 and sell it today you would lose (108.00) from holding Japan Medical Dynamic or give up 22.98% of portfolio value over 90 days. Japan Medical Dynamic is currently producing negative expected returns and takes up 1.4751% volatility of returns over 90 trading days. Put another way, 13% of traded stocks are less volatile than Japan, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Japan Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Japan Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Japan Medical Dynamic, and traders can use it to determine the average amount a Japan Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2645
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | JMD |
Estimated Market Risk
1.48 actual daily | 13 87% of assets are more volatile |
Expected Return
-0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Japan Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Japan Medical by adding Japan Medical to a well-diversified portfolio.
Japan Medical Fundamentals Growth
Japan Stock prices reflect investors' perceptions of the future prospects and financial health of Japan Medical, and Japan Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Japan Stock performance.
Return On Equity | 0.0758 | |||
Return On Asset | 0.0496 | |||
Profit Margin | 0.08 % | |||
Operating Margin | 0.10 % | |||
Current Valuation | 168.86 M | |||
Shares Outstanding | 26.38 M | |||
Price To Earning | 21.58 X | |||
Price To Book | 1.06 X | |||
Price To Sales | 0.01 X | |||
Revenue | 19.19 B | |||
EBITDA | 4.2 B | |||
Cash And Equivalents | 21.19 M | |||
Cash Per Share | 0.80 X | |||
Total Debt | 1.25 B | |||
Debt To Equity | 29.70 % | |||
Book Value Per Share | 871.68 X | |||
Cash Flow From Operations | 3.11 B | |||
Earnings Per Share | 0.43 X | |||
Total Asset | 27.34 B | |||
About Japan Medical Performance
By analyzing Japan Medical's fundamental ratios, stakeholders can gain valuable insights into Japan Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Japan Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Japan Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and internationally. Japan Medical Dynamic Marketing, INC. was founded in 1973 and is headquartered in Tokyo, Japan. Japan Medical is traded on Frankfurt Stock Exchange in Germany.Things to note about Japan Medical Dynamic performance evaluation
Checking the ongoing alerts about Japan Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Japan Medical Dynamic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Japan Medical generated a negative expected return over the last 90 days | |
About 43.0% of the company shares are held by company insiders |
- Analyzing Japan Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Japan Medical's stock is overvalued or undervalued compared to its peers.
- Examining Japan Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Japan Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Japan Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Japan Medical's stock. These opinions can provide insight into Japan Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Japan Stock analysis
When running Japan Medical's price analysis, check to measure Japan Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Japan Medical is operating at the current time. Most of Japan Medical's value examination focuses on studying past and present price action to predict the probability of Japan Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Japan Medical's price. Additionally, you may evaluate how the addition of Japan Medical to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |